An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
Title:
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
Author:
Aygören-Pürsün, Emel Zanichelli, Andrea Cohn, Danny M Cancian, Mauro Hakl, Roman Kinaciyan, Tamar Magerl, Markus Martinez-Saguer, Inmaculada Stobiecki, Marcin Farkas, Henriette Kiani-Alikhan, Sorena Grivcheva-Panovska, Vesna Bernstein, Jonathan A Li, H Henry Longhurst, Hilary J Audhya, Paul K Smith, Michael D Yea, Christopher M Maetzel, Andreas Lee, Daniel K Feener, Edward P Gower, Richard Lumry, William R Banerji, Aleena Riedl, Marc A Maurer, Marcus